Cargando…
A Bioinformatic Approach Based on Systems Biology to Determine the Effects of SARS-CoV-2 Infection in Patients with Hypertrophic Cardiomyopathy
Recently, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has infected millions of individuals worldwide. While COVID-19 generally affects the lungs, it also damages other organs, including those of the cardiovascular system....
Autores principales: | Han, Xiao, Wang, Fei, Yang, Ping, Di, Bin, Xu, Xiangdong, Zhang, Chunya, Yao, Man, Sun, Yaping, Lin, Yangyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532139/ https://www.ncbi.nlm.nih.gov/pubmed/36203534 http://dx.doi.org/10.1155/2022/5337380 |
Ejemplares similares
-
Identification of Potential Diagnostic Biomarkers and Biological Pathways in Hypertrophic Cardiomyopathy Based on Bioinformatics Analysis
por: Yu, Tingyan, et al.
Publicado: (2022) -
Systemic Bioinformatic Analyses of Nuclear-Encoded Mitochondrial Genes in Hypertrophic Cardiomyopathy
por: Tan, Zhaochong, et al.
Publicado: (2021) -
Severe SARS-CoV-2 Infection in a Cat with Hypertrophic Cardiomyopathy
por: Carvallo, Francisco R., et al.
Publicado: (2021) -
Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy
por: Velicki, Lazar, et al.
Publicado: (2020) -
Determinants of Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
por: Hwang, Ji-won, et al.
Publicado: (2022)